Logo
x

Search

Subscribe Now

Enrollment

Sorrento Initiates Enrollment in P-II MSC-COV-202BR Study for the Treatment of Acute Respiratory Distress due to COVID-19 in Brazil

Sorrento Initiates Enrollment in P-II MSC-COV-202BR Study for the Treatment of Acute Respiratory Distress due to COVID-19 in Brazi...

  • September 7, 2021
Xbrane Reports Patient Enrollment Completion in P-lll XPLORE Study of Xlucane (biosimilar- ranibizumab)

Xbrane Reports Patient Enrollment Completion in P-lll XPLORE Study of Xlucane (biosimilar- ranibizumab)

  • November 11, 2020
Eli Lilly Pauses Enrollment in ACTIV-3 Clinical Trial Due to Safety Concerns

Eli Lilly Pauses Enrollment in ACTIV-3 Clinical Trial Due to Safety Concerns

  • October 15, 2020
Strata Oncology Collaborates with Mirati Therapeutics to Broaden Enrollment in Clinical Trial of MRTX849 for Patients with Advanced Solid Tumors

Strata Oncology Collaborates with Mirati Therapeutics to Broaden Enrollment in Clinical Trial of MRTX849 for Patients with Advance...

  • August 13, 2020
FibroGen Report Enrollment of First Patient in P-II Study Evaluating Pamrevlumab in Patients Hospitalized with Acute COVID-19

FibroGen Report Enrollment of First Patient in P-II Study Evaluating Pamrevlumab in Patients Hospitalized with Acute COVID-19

  • June 24, 2020
BioInvent Reports the Enrollment of First Patient in P-I/IIa Study of BI-1206 + Keytruda for Solid Tumors

BioInvent Reports the Enrollment of First Patient in P-I/IIa Study of BI-1206 + Keytruda for Solid Tumors

  • June 23, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.